Cryptobiotix

🔬  Promising preclinical alleviation of dysbiosis in non-breastfed infants with Cow’s Milk Protein Allergy (CMPA) 🔬   📢 We are thrilled to announce our latest publication in gut microbiome research, in collaboration with Nestlé Health Science published in Beneficial Microbes.   🌐 Contributing to applied research with the potential to improve the quality of life of infants made this study particularly rewarding. We utilised the predictive, ex vivo SIFR technology to evaluate the potential of HMOs-lactose combinations to address dysbiosis in CMPA infants. Leveraging the high throughput of this validated methodology, 12 donors were included to map interpersonal differences.   📊 Key findings for lactose addition to HMO formulae: - stronger SCFA production - stimulation of HMO-utilising Bifidobacteriaceae and reduction in Clostridiaceae - stronger production of health-related metabolites pertaining to gut-brain axis, immune health, and gut motility   📈  We are happy to share those promising results, that will need to be confirmed in clinical trials.   🤝🏼 Thank you to all authors for your contribution: Pieter Van den Abbeele, Ralf Heine, Michiel Van de Vliet, Laurent Favre, Hanne Tytgat, Norbert Sprenger, Stef Deyaert, Aurélien Baudot and Sophie Nutten. Read the full study here: https://lnkd.in/eC_nt34Q #GutHealth #GutMicrobiome #MicrobiomeResearch #PreclinicalDataYouCanTrust #infants #research #exvivo #preclinical

🥕Eager to hear about the latest functional food trends on a global scale🥒    🚄 Meet our BD manager Ingmar van Hengel, PhD, at Food ingredients Europe next week. He is eager to discuss how to valorise your functional food ingredients. How? By generating #PreclinicalDataYouCanTrust about their impact on the microbiome and gut health. Our SIFR technology pipeline was designed to de-risk your clinical trials, and help you substantiate your claims, through: 🚀 #Highthroughput investigation across products and individuals 📈 Advanced #dataanalysis for maximal insight generation 🔬 Validated predictivity to minimise your risks in moving to the next step Let's connect and explore the future of food technology, nutrition, and gut microbiome research together!  #Nutrition #research #GutHealth #GutMicrobiome #MicrobiomeResearch #Preclinical #exvivo #SIFR #invitro 

📢 Restoring microbiota away from Bact2 status might improve intestinal barrier function in UC.   📊 We’re happy to share the latest publication of our very own Jonas Poppe. The altered faecal water metabolome in ulcerative colitis impacts functionally the colonic epithelium. Read the linked article to get all the details.

We are fully committed to pioneering and translating nutritional science into life-saving formulas for infants and children suffering from an allergy that are unable to breastfeed. Our extensive investment in our clinical program ensures that our hypoallergenic formulas provide essential nutrition for non-breastfed infants suffering from Cow's Milk Protein Allergy (CMPA) with the potential to improve quality of life, both in the short and long term. 📢 We are thrilled to announce the publication of an ex-vivo study: https://lnkd.in/gcGsUx5f revealing data that supports the alleviation of dysbiosis in non-breastfed Infants with CMPA! This research, published in collaboration with Cryptobiotix in Beneficial Microbes, focuses on the impact of two human milk oligosaccharides and lactose on the faecal microbiome of infants with probable cow’s milk protein allergy. 📈 These promising results pave the way for future clinical trials, confirming the potential benefits for CMPA patients! *Information for Healthcare Professionals #CMPA #Nutrition #Science #GutHealth #Microbiome #Research #PromisingResult

📢Join us at the Europe Nutraceutical & Functional Food Summit! 📢 🚗 Our CEO, Aurélien Baudot, will be in Brussels in the coming days to explore product innovations across the industry and tackle your preclinical research issues. This conference is taking place in his hometown, so don’t hesitate to ask for local recommendations as well! We developed the SIFR technology to generate #PreclinicalDataYouCanTrust, based on: 🚀 #Highthroughput simulation 📈 Advanced #dataanalysis 🔬 Validated predictivity Let's connect and explore the future of food technology, nutrition, and gut microbiome research together! #Nutrition #research #GutHealth #GutMicrobiome #MicrobiomeResearch  #Preclinical #exvivo #SIFR #invitro

♠️ ️ Don't gamble with preclinical research! ♠️ ️ 🛫 Ingmar van Hengel, PhD, BD manager, will attend SupplySide West 2024 next week and help you de-risk your preclinical game. The only bridge we are interested in is the one spanning the gap between preclinical insights and clinical reality. We developed the SIFR technology to generate PreclinicalDataYouCanTrust, based on: 🚀 #Highthroughput simulation 📈 Advanced #dataanalysis 🔬 Validated predictivity Let's connect and explore the future of food technology, nutrition, and gut microbiome research together! #Nutrition #research #GutHealth #GutMicrobiome #MicrobiomeResearch  #Preclinical SupplySide Network

🍼 Can we help allergic infants through gut microbiome modulation? Join Aurélien Baudot next week at the Microbiome & Probiotics R&D and Business Collaboration, and find out. 🎤 Our CEO will introduce the predictive SIFR technology, before presenting the latest results of a collaboration with Nestlé Health Science, exploring the impact across omics of various HMOs in combination to lactose. 📍 San Diego, USA 🗓️ Wed 17 Oct @ 12.30 pm We developed the SIFR technology to bridge the gap between preclinical insights and clinical reality, by generating #PreclinicalDataYouCanTrust. This is possible through: 🚀 #Highthroughput 📈 Advanced #dataanalysis 🔬 Extensive validation Let's connect and explore the future of food technology, nutrition, and gut microbiome research together! #Nutrition #research #GutHealth #GutMicrobiome #MicrobiomeResearch  #Preclinical #MicrobiomeForum

Read our CEO's thoughts on the potential of targeting the gut microbiome in food products as well as the obstacles to overcome. Join the discussion this Wed/Thu at Future Food-Tech, London, and connect with Aurélien Baudot and Ingmar van Hengel, PhD to discuss how it applies to your innovation goals.

🔬Expanding microbiome frontiers! 📢 Join us at Future Food-Tech London and let's help the industry understand and leverage the gut microbiome! Our experts, Aurélien Baudot and Ingmar van Hengel, PhD , will be on site to engage in meaningful discussions about your functional ingredients. Interested? Contact us through the app, at the booth, or come listen to Ingmar’s pitch on Wed 2, 4pm! We created a unique pipeline, the SIFR technology, to bridge the gap between preclinical insights and clinical reality, by generating #PreclinicalDataYouCanTrust. This is possible through: 🚀 #Highthroughput 📈 Advanced #dataanalysis 🎯 Extensive validation Let's connect and explore the future of food technology, nutrition, and gut microbiome research together! #FoodTech #Nutrition #research #GutHealth #GutMicrobiome #MicrobiomeResearch 

Cryptobiotix provides preclinical microbiome and digestion data with clinical predictivity to speed up and de-risk product development.   Using innovative technologies to elucidate how ingested actives are affected by digestion, the Belgian scale-up is pushing the boundaries of preclinical research in the field.   To learn more about its innovative SIFR technology, hear from Ingmar van Hengel, PhD, Business Development Manager, in the Scale-Up Pitching Session at #FutureFoodTech on Wednesday, October 2 at 4pm: https://bit.ly/3LawswA